Principles of Tissues Engineering

by Robert Lanza, Robert S. Langer (Contributor)

The depth and breadth of opportunity that tissue engineering provides for medicine is extraordinary. In the U.S. alone, it is estimated that nearly half-a-trillion dollars are spent each year to care for patients who suffer either tissue loss or end-stage organ failure. Although individual papers on various aspects of tissue engineering abound, no previous work has satisfactorily integrated this new interdisciplinary subject area. This book combines in one volume the prerequisites for a general understanding of tissue growth and development, the tools and theoretical information needed to design tissues and organs, as well as a presentation of applications of tissue engineering to diseases affecting specific organ systems. The book strikes a balance among the diversity of subjects that are related to tissue engineering, including biology, chemistry, material science, engineering, immunology and transplantation among others, while emphasizing those research areas that are likely to be of most value to medicine in the future.

808 pages, Hardcover

First published January 1, 1997

About the author

ROBERT LANZA, MD, is one of the most respected scientists in the world. He is head of Astellas Global Regenerative Medicine, Chief Scientific Officer of the Astellas Institute for Regenerative Medicine, and adjunct professor at Wake Forest School of Medicine. TIME magazine recognized him as one of the “100 Most Influential People in the World,” and Prospect magazine named him one of the Top 50 “World Thinkers” in 2015. He is credited with several hundred publications and inventions, and more than 30 scientific books, including the definitive references in the field of stem cells and regenerative medicine. A former Fulbright Scholar, he studied with polio pioneer Jonas Salk and Nobel Laureates Gerald Edelman and Rodney Porter. Lanza was part of the team that cloned the world’s first human embryo, as well as the first to successfully generate stem cells from adults using somatic-cell nuclear transfer (therapeutic cloning).